PCI Complications: Coronary Spasm: Difference between revisions
Jump to navigation
Jump to search
m (Robot: Automated text replacement (-{{SIB}} +, -{{EH}} +, -{{EJ}} +, -{{Editor Help}} +, -{{Editor Join}} +)) |
No edit summary |
||
| (2 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
{{SI}} | {{SI}} | ||
'''Editors-In-Chief''': Alexandra Almonacid M.D. and Jeffrey J. Popma M.D. | '''Editors-In-Chief''': Alexandra Almonacid M.D. and Jeffrey J. Popma M.D. | ||
==Definition== | ==Definition== | ||
| Line 11: | Line 8: | ||
==Incidence== | ==Incidence== | ||
Coronary spasm may be present in approximately 5% of cases, but its frequency has been reduced with the routine use of coronary vasodilators, such as nitroglycerin and calcium channel blockers. Wire straightening of the vessel can mimic coronary spasm. | Coronary spasm may be present in approximately 5% of cases, but its frequency has been reduced with the routine use of coronary vasodilators, such as nitroglycerin and calcium channel blockers. Wire straightening of the vessel can mimic coronary spasm. | ||
[[Category:Cardiology]] | [[Category:Cardiology]] | ||
Latest revision as of 16:47, 19 October 2012
Editors-In-Chief: Alexandra Almonacid M.D. and Jeffrey J. Popma M.D.
Definition
Coronary spasm is commonly defined as a transient or sustained reduction in the diameter stenosis by more than 50% in an arterial segment with insignificant (< 25%) baseline narrowing.
Incidence
Coronary spasm may be present in approximately 5% of cases, but its frequency has been reduced with the routine use of coronary vasodilators, such as nitroglycerin and calcium channel blockers. Wire straightening of the vessel can mimic coronary spasm.